Sarissa Capital Management LP Long-Term Concentrated

Location: Greenwich, CT

CIK: 0001577524 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value: $1.058B (100.0% shares, 0.0% debt)

Holdings (11)

ALKS ALKERMES PLC 34.9%

Value $369M Shares 14,040,000 Est. Cost $21.05 Unrealized +17.7%

IRWD IRONWOOD PHARMACEUTICALS INC 19.5%

Value $206M Shares 16,390,000 Est. Cost $11.52 Unrealized -0.5%

BIIB BIOGEN INC 12.8%

Value $135M Shares 643,000 Est. Cost $278.12 Unrealized -21.8%

INVA INNOVIVA INC 12.1%

Value $128M Shares 6,614,000 Est. Cost $13.07 Unrealized +36.7%

GILD GILEAD SCIENCES INC 8.8%

Value $92.91M Shares 1,562,900 Est. Cost $53.90 Unrealized +2.3%

— AMARIN CORP PLC 7.5%

Value $78.96M Shares 24,000,000 Est. Cost $3.97 Unrealized —

BCRX BIOCRYST PHARMACEUTICALS INC 2.1%

Value $22.61M Shares 1,390,790 Est. Cost $4.84 Unrealized +231.3%

— MERSANA THERAPEUTICS INC 1.6%

Value $17.15M Shares 4,299,297 Est. Cost $9.56 Unrealized —

— VOR BIOPHARMA INC 0.4%

Value $4.27M Shares 707,010 Est. Cost $43.10 Unrealized —

— PEAR THERAPEUTICS INC 0.2%

Value $2.527M Shares 500,356 Est. Cost $6.20 Unrealized —

— REGULUS THERAPEUTICS INC 0.1%

Value $552K Shares 1,851,851 Est. Cost $1.25 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ALKS	ALKERMES PLC	14,040,000	$369M	34.9%	$21.05	+17.7%	SHS	G01767105
IRWD	IRONWOOD PHARMACEUTICALS INC	16,390,000	$206M	19.5%	$11.52	-0.5%	COM CL A	46333X108
BIIB	BIOGEN INC	643,000	$135M	12.8%	$278.12	-21.8%	COM	09062X103
INVA	INNOVIVA INC	6,614,000	$128M	12.1%	$13.07	+36.7%	COM	45781M101
GILD	GILEAD SCIENCES INC	1,562,900	$92.91M	8.8%	$53.90	+2.3%	COM	375558103
—	AMARIN CORP PLC	24,000,000	$78.96M	7.5%	$3.97	—	SPONS ADR NEW	023111206
BCRX	BIOCRYST PHARMACEUTICALS INC	1,390,790	$22.61M	2.1%	$4.84	+231.3%	COM	09058V103
—	MERSANA THERAPEUTICS INC	4,299,297	$17.15M	1.6%	$9.56	—	COM	59045L106
—	VOR BIOPHARMA INC	707,010	$4.27M	0.4%	$43.10	—	COM	929033108
—	PEAR THERAPEUTICS INC	500,356	$2.527M	0.2%	$6.20	—	CLASS A COM	704723105
—	REGULUS THERAPEUTICS INC	1,851,851	$552K	0.1%	$1.25	—	COM NEW	75915K200